Pasar al contenido principal

IMPLICACION DE NR4A2/NURR1 EN LA DISFUNCION SINAPTICA Y DEFICITS COGNITIVOS EN FASES TEMPRANAS DE LA ENFERMEDAD DE ALZHEIMER

SAF2017-89271-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Nr4a2 Transcription Factor in Hippocampal Synaptic Plasticity, Memory and Cognitive Dysfunction, A Perspective Review

  • Català-Solsona, Judit|||0000-0002-2927-9135
  • Miñano Molina, Alfredo Jesús|||0000-0002-7761-5682
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
Long-lasting changes of synaptic efficacy are largely mediated by activity-induced gene transcription and are essential for neuronal plasticity and memory. In this scenario, transcription factors have emerged as pivotal players underlying synaptic plasticity and the modification of neural networks required for memory formation and consolidation. Hippocampal synaptic dysfunction is widely accepted to underlie the cognitive decline observed in some neurodegenerative disorders including Alzheimer's disease. Therefore, understanding the molecular pathways regulating gene expression profiles may help to identify new synaptic therapeutic targets. The nuclear receptor 4A subfamily (Nr4a) of transcription factors has been involved in a variety of physiological processes within the hippocampus, ranging from inflammation to neuroprotection. Recent studies have also pointed out a role for the activity-dependent nuclear receptor subfamily 4, group A, member 2 (Nr4a2/Nurr1) in hippocampal synaptic plasticity and cognitive functions, although the underlying molecular mechanisms are still poorly understood. In this review, we highlight the specific effects of Nr4a2 in hippocampal synaptic plasticity and memory formation and we discuss whether the dysregulation of this transcription factor could contribute to hippocampal synaptic dysfunction, altogether suggesting the possibility that Nr4a2 may emerge as a novel synaptic therapeutic target in brain pathologies associated to cognitive dysfunctions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition

  • Solé Piñol, Montserrat|||0000-0003-4240-6562
  • Esteban-Lopez, María|||0000-0002-5897-3003
  • Taltavull, Biel
  • Fábregas Ordóñez, Cristina|||0009-0001-8549-6599
  • Fadó, Rut|||0000-0002-3293-2342
  • Casals, Nuria|||0000-0002-6719-4300
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
  • Miñano Molina, Alfredo Jesús|||0000-0002-7761-5682
  • Unzeta López, Mercedes|||0000-0002-7113-3383
Dysfunctions of the vascular system directly contribute to the onset and progression of Alzheimer's disease (AD). The blood-brain barrier (BBB) shows signs of malfunction at early stages of the disease. When Abeta peptide (Aβ) is deposited on brain vessels, it induces vascular degeneration by producing reactive oxygen species and promoting inflammation. These molecular processes are also related to an excessive SSAO/VAP-1 (semicarbazide-sensitive amine oxidase) enzymatic activity, observed in plasma and in cerebrovascular tissue of AD patients. We studied the contribution of vascular SSAO/VAP-1 to the BBB dysfunction in AD using in vitro BBB models. Our results show that SSAO/VAP-1 expression is associated to endothelial activation by altering the release of pro-inflammatory and pro-angiogenic angioneurins, most highly IL-6, IL-8 and VEGF. It is also related to a BBB structure alteration, with a decrease in tight-junction proteins such as zona occludens or claudin-5. Moreover, the BBB function reveals increased permeability and leukocyte adhesion in cells expressing SSAO/VAP-1, as well as an enhancement of the vascular Aβ deposition induced by mechanisms both dependent and independent of the enzymatic activity of SSAO/VAP-1. These results reveal an interesting role of vascular SSAO/VAP-1 in BBB dysfunction related to AD progression, opening a new window in the search of alternative therapeutic targets for fighting AD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Synaptic vulnerability to amyloid-β and tau pathologies differentially disrupts emotional and memory neural circuits

  • Capilla López, Maria Dolores|||0000-0002-9483-4887
  • Deprada Fernández, Ángel|||0000-0002-7860-6307
  • Andrade-Talavera, Yuniesky|||0000-0002-5295-0169
  • Martínez Gallego, Irene|||0000-0002-8936-8201
  • Coatl-Cuaya, Heriberto|||0000-0003-4953-6562
  • Sotillo Sotillo, Paula
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
  • Rodríguez Moreno, Antonio|||0000-0002-8078-6175
  • Parra-Damas, Arnaldo|||0000-0001-5683-060X
  • Saura Antolín, Carlos|||0000-0003-3692-5657
Alzheimer's disease (AD) is characterized by memory loss and neuropsychiatric symptoms associated with cerebral amyloid-β (Aβ) and tau pathologies, but whether and how these factors differentially disrupt neural circuits remains unclear. Here, we investigated the vulnerability of memory and emotional circuits to Aβ and tau pathologies in mice expressing mutant human amyloid precursor protein (APP), Tau or both APP/Tau in excitatory neurons. APP/Tau mice develop age- and sex-dependent Aβ and phosphorylated tau pathologies, the latter exacerbated at early stages, in vulnerable brain regions. Early memory deficits were associated with hippocampal tau pathology in Tau and APP/Tau mice, whereas anxiety and fear appeared linked to intracellular Aβ in the basolateral amygdala (BLA) of APP and APP/Tau mice. Transcriptome hippocampal profiling revealed gene changes affecting myelination and RNA processing in Tau mice, and inflammation and synaptic-related pathways in APP/Tau mice at 6 months. At 9 months, we detected common and region-specific changes in astrocytic, microglia and 63 AD-associated genes in the hippocampus and BLA of APP/Tau mice. Spatial learning deficits were associated with synaptic tau accumulation and synapse disruption in the hippocampus of Tau and APP/Tau mice, whereas emotional disturbances were linked to Aβ pathology but not synaptic tau in the BLA. Interestingly, Aβ and tau exhibited synergistic detrimental effects in long-term potentiation (LTP) in the hippocampus but they counteract with each other to mitigate LTP impairments in the amygdala. These findings indicate that Aβ and tau pathologies cause region-specific effects and synergize to induce synaptic dysfunction and immune responses, contributing to the differing vulnerability of memory and emotional neural circuits in AD.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Proteasomal-mediated degradation of AKAP150 accompanies AMPAR endocytosis during cLTD

  • Cheng, Wenwen
  • Siedlecki-Wullich, Dolores
  • Català-Solsona, Judit
  • Fábregas, Cristina
  • Fadó Andrés, Rut
  • Casals i Farré, Núria
  • Solé, Montse
  • Unzeta, Mercedes
  • Saura, Carlos A.
  • Rodríguez-Álvarez, José
  • Miñano Molina, Alfredo Jesús
The number and function of synaptic AMPA receptors (AMPARs) tightly regulates excitatory synaptic transmission. Current evidence suggests that AMPARs are inserted into the postsynaptic membrane during long-term potentiation (LTP) and are removed from the membrane during long-term depression (LTD). Dephosphorylation of GluA1 at Ser-845 and enhanced endocytosis are critical events in the modulation of LTD. Moreover, changes in scaffold proteins from the postsynaptic density (PSD) could be also related to AMPAR regulation in LTD. In the present study we analyzed the effect of chemical LTD (cLTD) on A-kinase anchoring protein (AKAP)150 and AMPARs levels in mouse-cultured neurons. We show that cLTD induces AKAP150 protein degradation via proteasome, coinciding with GluA1 dephosphorylation at Ser-845 and endocytosis of GluA1-containing AMPARs. Pharmacological inhibition of proteasome activity, but not phosphatase calcineurin (CaN), reverted cLTD-induced AKAP150 protein degradation. Importantly, AKAP150 silencing induced dephosphorylation of GluA1 Ser-845 and GluA1-AMPARs endocytosis while AKAP150 overexpression blocked cLTD-mediated GluA1-AMPARs endocytosis. Our results provide direct evidence that cLTD-induced AKAP150 degradation by the proteasome contributes to synaptic AMPARs endocytosis., info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sensing of nutrients by CPT1C controls SAC1 activity to regulate AMPA receptor trafficking

  • Casas Prat, Maria
  • Fadó Andrés, Rut
  • Domínguez, José Luis
  • Roig, Aina
  • Kaku, Moena
  • Chohnan_, Shigeru
  • Solé, Montse
  • UNZETA, Mercedes
  • Miñano-Molina, Alfredo J
  • Rodriguez-Alvarez, Jose
  • Dickson, Eamonn
  • Casals, Nuria
This work was partially supported by Ministerio de Economia y Competitividad from Spain (grant SAF2017-82813-C3-3R to N. Casals, grant SAF2017-89271-R to J. Rodríguez-Alvarez, cofunded by the European Regional Development Fund), Centro de Investigación Biomedica en Red Fisiopatología de la Obesidad y la Nutrición (grant CB06/03/0001 to N. Casals), Centro de Investigación Biomedica en Red sobre Enfermedades Neurodegenerativas (grant CB06/05/0042 to J. Rodríguez-Alvarez), Generalitat de Catalunya (2014SGR465 to N. Casals, SGR2014-0984 to J. Rodríguez-Alvarez), Fundació La Marató de TV3 (grant 87/C/2016 to N. Casals, grant 2014-3610 to J. Rodríguez Alvarez), University of California funds (to E.J. Dickson)., Carnitine palmitoyltransferase 1C (CPT1C) is a sensor of malonyl-CoA and is located in the ER of neurons. AMPA receptors (AMPARs) mediate fast excitatory neurotransmission in the brain and play a key role in synaptic plasticity. In the present study, we demonstrate across different metabolic stress conditions that modulate malonyl-CoA levels in cortical neurons that CPT1C regulates the trafficking of the major AMPAR subunit, GluA1, through the phosphatidyl-inositol-4-phosphate (PI(4)P) phosphatase SAC1. In normal conditions, CPT1C down-regulates SAC1 catalytic activity, allowing efficient GluA1 trafficking to the plasma membrane. However, under low malonyl-CoA levels, such as during glucose depletion, CPT1C-dependent inhibition of SAC1 is released, facilitating SAC1’s translocation to ER-TGN contact sites to decrease TGN PI(4)P pools and trigger GluA1 retention at the TGN. Results reveal that GluA1 trafficking is regulated by CPT1C sensing of malonyl-CoA and provide the first report of a SAC1 inhibitor. Moreover, they shed light on how nutrients can affect synaptic function and cognition., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sensing of nutrients by CPT1C controls SAC1 activity to regulate AMPA receptor trafficking

  • Casas, Maria
  • Rut, Fadó
  • Domínguez, José Luis
  • Roig, Aina
  • Kaku, Moena
  • Chohnan, Shigeru
  • Solé, Montse
  • Unzeta, Mercedes
  • Miñano Molina, Alfredo Jesús
  • Rodríguez-Álvarez, José
  • James Dickson, Eamonn
  • Casals i Farré, Núria
This work was partially supported by Ministerio de Economia y Competitividad from Spain (grant SAF2017-82813-C3-3R to N. Casals, grant SAF2017-89271-R to J. Rodr´ıguez-Alvarez, cofunded by the European Regional Development Fund), Centro de Investigación Biomedica en Red Fisiopatologıa de la Obesidad y la Nutrición (grant CB06/03/0001 to N. Casals), Centro de Investigación Biomedica en Red sobre Enfermedades Neuro- degenerativas (grant CB06/05/0042 to J. Rodrıguez-Alvarez), Generalitat de Catalunya (2014SGR465 to N. Casals, SGR2014-0984 to J. Rodr´ıguez-Alvarez), Fundació La Marató de TV3 (grant 87/C/2016 to N. Casals, grant 2014-3610 to J. Rodr´ıguezAlvarez), University of California funds (to E.J. Dickson), and National Institutes of Health grant R01 GM127513 (to E.J. Dickson)., Carnitine palmitoyltransferase 1C (CPT1C) is a sensor of malonyl-CoA and is located in the ER of neurons. AMPA receptors (AMPARs) mediate fast excitatory neurotransmission in the brain and play a key role in synaptic plasticity. In the present study, we demonstrate across different metabolic stress conditions that modulate malonyl-CoA levels in cortical neurons that CPT1C regulates the trafficking of the major AMPAR subunit, GluA1, through the phosphatidyl-inositol-4-phosphate (PI(4)P) phosphatase SAC1. In normal conditions, CPT1C down-regulates SAC1 catalytic activity, allowing efficient GluA1 trafficking to the plasma membrane. However, under low malonyl-CoA levels, such as during glucose depletion, CPT1C-dependent inhibition of SAC1 is released, facilitating SAC1’s translocation to ER-TGN contact sites to decrease TGN PI(4)P pools and trigger GluA1 retention at the TGN. Results reveal that GluA1 trafficking is regulated by CPT1C sensing of malonyl-CoA and provide the first report of a SAC1 inhibitor. Moreover, they shed light on how nutrients can affect synaptic function and cognition., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sensing of nutrients by CPT1C controls SAC1 activity to regulate AMPA receptor trafficking

  • Casas, Maria
  • Fadó Andrés, Rut
  • Domínguez, José Luis
  • Roig, Aina
  • Kaku, Moena
  • Chohnan, Shigeru
  • Solé, Montse
  • Unzeta, Mercedes
  • Miñano Molina, Alfredo Jesús
  • Rodríguez-Álvarez, José
  • Dickson, Eamonn James
  • Casals i Farré, Núria
This work was partially supported by Ministerio de Economia y Competitividad from Spain (grant SAF2017-82813-C3-3R to N. Casals, grant SAF2017-89271-R to J. Rodrıguez-Alvarez, cofunded ´by the European Regional Development Fund), Centro de Investigación Biomedica en Red Fisiopatologıa de la Obesidad y la Nutrición (grant CB06/03/0001 to N. Casals), Centro de Investigación Biomedica en Red sobre Enfermedades Neuro- ´degenerativas (grant CB06/05/0042 to J. Rodrıguez-Alvarez), ´Generalitat de Catalunya (2014SGR465 to N. Casals, SGR2014-0984 to J. Rodr´ıguez-Alvarez), Fundació La Marató de TV3 ´(grant 87/C/2016 to N. Casals, grant 2014-3610 to J. RodrıguezAlvarez), University of California funds (to E.J. Dickson), and ´National Institutes of Health grant R01 GM127513 (to E.J. Dickson)., Carnitine palmitoyltransferase 1C (CPT1C) is a sensor of malonyl-CoA and is located in the ER of neurons. AMPA receptors (AMPARs) mediate fast excitatory neurotransmission in the brain and play a key role in synaptic plasticity. In the present study, we demonstrate across different metabolic stress conditions that modulate malonyl-CoA levels in cortical neurons that CPT1C regulates the trafficking of the major AMPAR subunit, GluA1, through the phosphatidyl-inositol-4-phosphate (PI(4)P) phosphatase SAC1. In normal conditions, CPT1C down-regulates SAC1 catalytic activity, allowing efficient GluA1 trafficking to the plasma membrane. However, under low malonyl-CoA levels, such as during glucose depletion, CPT1C-dependent inhibition of SAC1 is released, facilitating SAC1’s translocation to ER-TGN contact sites to decrease TGN PI(4)P pools and trigger GluA1 retention at the TGN. Results reveal that GluA1 trafficking is regulated by CPT1C sensing of malonyl-CoA and provide the first report of a SAC1 inhibitor. Moreover, they shed light on how nutrients can affect synaptic function and cognition., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease

  • Siedlecki-Wullich, Dolores|||0000-0002-9099-9406
  • Català-Solsona, Judit|||0000-0002-2927-9135
  • Fábregas Ordóñez, Cristina
  • Hernández, Isabel|||0000-0001-8119-393X
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Lleó, Alberto|||0000-0002-2568-5478
  • Boada, Mercè|||0000-0003-2617-3009
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
  • Miñano Molina, Alfredo Jesús|||0000-0002-7761-5682
Several evidences suggest that failure of synaptic function occurs at preclinical stages of Alzheimer's disease (AD) preceding neuronal loss and the classical AD pathological hallmarks. Nowadays, there is an urgent need to identify reliable biomarkers that could be obtained with non-invasive methods to improve AD diagnosis at early stages. Here, we have examined plasma levels of a group of miRNAs related to synaptic proteins in a cohort composed of cognitive healthy controls (HC), mild cognitive impairment (MCI) and AD subjects. Plasma and brain levels of miRNAs were analysed in two different cohorts including 38 HC, 26 MCI, 56 AD dementia patients and 27 frontotemporal dementia (FTD) patients. D'Agostino and Pearson and Shapiro-Wilk tests were used to evaluate data normality. miRNA levels between groups were compared using a two-sided nonparametric Mann-Whitney test and sensitivity and specificity was determined by receiver operating characteristic curve analysis. Significant upregulation of miR-92a-3p, miR-181c-5p and miR-210-3p was found in the plasma of both MCI and AD subjects. MCI patients that progress to AD showed higher plasma levels of these miRNAs. By contrast, no changes in miR-92a-3p, miR-181c-5p or miR-210-3p levels were observed in plasma obtained from a cohort of FTD. Our study shows that plasma miR-92a-3p, miR-181c-5p and miR-210-3p constitute a specific molecular signature potentially useful as a potential biomarker for AD. The online version of this article (10.1186/s13195-019-0501-4) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Proteasomal-Mediated Degradation of AKAP150 Accompanies AMPAR Endocytosis during cLTD

  • Cheng, Wenwen|||0000-0002-5462-8245
  • Siedlecki-Wullich, Dolores|||0000-0002-9099-9406
  • Català-Solsona, Judit|||0000-0002-2927-9135
  • Fábregas Ordóñez, Cristina
  • Fadó, Rut|||0000-0002-3293-2342
  • Casals, Nuria|||0000-0002-6719-4300
  • Solé Piñol, Montserrat|||0000-0003-4240-6562
  • Unzeta López, Mercedes|||0000-0002-7113-3383
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
  • Miñano Molina, Alfredo Jesús|||0000-0002-7761-5682
The number and function of synaptic AMPA receptors (AMPARs) tightly regulates excitatory synaptic transmission. Current evidence suggests that AMPARs are inserted into the postsynaptic membrane during long-term potentiation (LTP) and are removed from the membrane during long-term depression (LTD). Dephosphorylation of GluA1 at Ser-845 and enhanced endocytosis are critical events in the modulation of LTD. Moreover, changes in scaffold proteins from the postsynaptic density (PSD) could be also related to AMPAR regulation in LTD. In the present study we analyzed the effect of chemical LTD (cLTD) on A-kinase anchoring protein (AKAP)150 and AMPARs levels in mouse-cultured neurons. We show that cLTD induces AKAP150 protein degradation via proteasome, coinciding with GluA1 dephosphorylation at Ser-845 and endocytosis of GluA1-containing AMPARs. Pharmacological inhibition of proteasome activity, but not phosphatase calcineurin (CaN), reverted cLTD-induced AKAP150 protein degradation. Importantly, AKAP150 silencing induced dephosphorylation of GluA1 Ser-845 and GluA1-AMPARs endocytosis while AKAP150 overexpression blocked cLTD-mediated GluA1-AMPARs endocytosis. Our results provide direct evidence that cLTD-induced AKAP150 degradation by the proteasome contributes to synaptic AMPARs endocytosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MicroRNAs as Early Biomarkers of Alzheimer's Disease, a synaptic perspective

  • Siedlecki-Wullich, Dolores|||0000-0002-9099-9406
  • Miñano Molina, Alfredo Jesús|||0000-0002-7761-5682
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
Pathogenic processes underlying Alzheimer's disease (AD) affect synaptic function from initial asymptomatic stages, long time before the onset of cognitive decline and neurodegeneration. Therefore, reliable biomarkers enabling early AD diagnosis and prognosis are needed to maximize the time window for therapeutic interventions. MicroRNAs (miRNAs) have recently emerged as promising cost-effective and non-invasive biomarkers for AD, since they can be readily detected in different biofluids, including cerebrospinal fluid (CSF) and blood. Moreover, a growing body of evidence indicates that miRNAs regulate synaptic homeostasis and plasticity processes, suggesting that they may be involved in early synaptic dysfunction during AD. Here, we review the current literature supporting a role of miRNAs during early synaptic deficits in AD, including recent studies evaluating their potential as AD biomarkers. Besides targeting genes related to Aβ and tau metabolism, several miRNAs also regulate synaptic-related proteins and transcription factors implicated in early synaptic deficits during AD. Furthermore, individual miRNAs and molecular signatures have been found to distinguish between prodromal AD and healthy controls. Overall, these studies highlight the relevance of considering synaptic-related miRNAs as potential biomarkers of early AD stages. However, further validation studies in large cohorts, including longitudinal studies, as well as implementation of standardized protocols, are needed to establish miRNA-based biomarkers as reliable diagnostic and prognostic tools.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sensing of nutrients by CPT1C controls SAC1 activity to regulate AMPA receptor trafficking

  • Casas, Maria|||0000-0002-5246-8874
  • Fadó, Rut|||0000-0002-3293-2342
  • Domínguez, José Luis
  • Roig, Aina
  • Kaku, Moena
  • Chohnan, Shigeru|||0000-0002-4624-927X
  • Solé Piñol, Montserrat|||0000-0003-4240-6562
  • Unzeta López, Mercedes|||0000-0002-7113-3383
  • Miñano Molina, Alfredo Jesús|||0000-0002-7761-5682
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
  • Dickson, Eamonn James|||0000-0001-8619-7630
  • Casals, Nuria|||0000-0002-6719-4300
GuA1-containing AMPA receptors play a key role in synaptic plasticity and cognition. Casas et al. demonstrate that the sensing of nutrients by CPT1C regulates the phosphatase activity of SAC1, and consequently PI(4)P levels, at the contact sites between the endoplasmic reticulum and the trans-Golgi network to control the trafficking of GluA1 receptors to the cell surface of neurons. Carnitine palmitoyltransferase 1C (CPT1C) is a sensor of malonyl-CoA and is located in the ER of neurons. AMPA receptors (AMPARs) mediate fast excitatory neurotransmission in the brain and play a key role in synaptic plasticity. In the present study, we demonstrate across different metabolic stress conditions that modulate malonyl-CoA levels in cortical neurons that CPT1C regulates the trafficking of the major AMPAR subunit, GluA1, through the phosphatidyl-inositol-4-phosphate (PI(4)P) phosphatase SAC1. In normal conditions, CPT1C down-regulates SAC1 catalytic activity, allowing efficient GluA1 trafficking to the plasma membrane. However, under low malonyl-CoA levels, such as during glucose depletion, CPT1C-dependent inhibition of SAC1 is released, facilitating SAC1's translocation to ER-TGN contact sites to decrease TGN PI(4)P pools and trigger GluA1 retention at the TGN. Results reveal that GluA1 trafficking is regulated by CPT1C sensing of malonyl-CoA and provide the first report of a SAC1 inhibitor. Moreover, they shed light on how nutrients can affect synaptic function and cognition.